A tumor-restricted glycoepitope of podocalyxin correlates with immune evasion in high-grade serous ovarian carcinoma.

被引:0
|
作者
Brassard, Julyanne
Hernaez, Diana Canals
Hughes, Michael R.
Milne, Katy
Dean, Pamela
Warren, Mary
Zhang, Kevin
Banville, Allyson C.
Smazynski, Julian
Bond, David
Nelson, Brad H.
Roskelley, Calvin D.
McNagny, Kelly M.
机构
来源
JOURNAL OF IMMUNOLOGY | 2022年 / 208卷 / 01期
基金
加拿大健康研究院;
关键词
D O I
10.4049/jimmunol.208.Supp.177.10
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
177.10
引用
收藏
页数:2
相关论文
共 50 条
  • [1] A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma
    Brassard, Julyanne
    Hughes, Michael R.
    Dean, Pamela
    Hernaez, Diana Canals
    Thornton, Shelby
    Banville, Allyson C.
    Smazynski, Julian
    Warren, Mary
    Zhang, Kevin
    Milne, Katy
    Gilks, C. Blake
    Mes-Masson, Anne-Marie
    Huntsman, David G.
    Nelson, Brad H.
    Roskelley, Calvin D.
    Mcnagny, Kelly M.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [2] Defining the tumor immune landscape in a mouse model of high-grade serous carcinoma.
    McCool, Kevin W.
    Kuick, Rork
    Zhai, Yali
    Freeman, Zach
    Wu, Rong
    Fearon, Eric
    Cho, Kathleen R.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 113 - 114
  • [3] Giant cancer stem cells of high-grade ovarian serous carcinoma.
    Liu, Jinsong
    CLINICAL CANCER RESEARCH, 2016, 22
  • [4] Racial differences in the tumor immune landscape and survival of high-grade serous ovarian carcinoma
    Peres, Lauren C.
    Colin-Leitzinger, Christelle
    Sinha, Sweta
    Marks, Jeffrey R.
    Conejo-Garcia, Jose R.
    Alberg, Anthony J.
    Bandera, Elisa V.
    Berchuck, Andrew
    Bondy, Melissa L.
    Christensen, Brock C.
    Cote, Michele L.
    Doherty, Jennifer A.
    Moorman, Patricia G.
    Segura, Carlos Moran
    Nguyen, Jonathan V.
    Peters, Edward S.
    Schwartz, Ann G.
    Terry, Paul D.
    Wilson, Christopher M.
    Fridley, Brooke L.
    Schildkraut, Joellen M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [5] Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma
    Peres, Lauren C.
    Colin-Leitzinger, Christelle
    Sinha, Sweta
    Marks, Jeffrey R.
    Conejo-Garcia, Jose R.
    Alberg, Anthony J.
    Bandera, Elisa, V
    Berchuck, Andrew
    Bondy, Melissa L.
    Christensen, Brock C.
    Cote, Michele L.
    Doherty, Jennifer Anne
    Moorman, Patricia G.
    Peters, Edward S.
    Segura, Carlos Moran
    Nguyen, Jonathan, V
    Schwartz, Ann G.
    Terry, Paul D.
    Wilson, Christopher M.
    Fridley, Brooke L.
    Schildkraut, Joellen M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (05) : 1006 - 1016
  • [6] The tumor immune microenvironment correlates with neoadjuvant chemotherapy response in high-grade serous ovarian cancer.
    Zhu, Lei
    Cao, Guangming
    Hua, Dingchao
    Cui, Lina
    Zhao, Xiaochen
    Wang, Shuzhen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17605 - E17605
  • [7] Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
    Kanno, Kosuke
    Nakayama, Kentaro
    Razia, Sultana
    Islam, Sohel Hasibul
    Farzana, Zahan Umme
    Sonia, Shahataj Begum
    Sasamori, Hiroki
    Yamashita, Hitomi
    Ishibashi, Tomoka
    Ishikawa, Masako
    Imamura, Kayo
    Ishikawa, Noriyoshi
    Kyo, Satoru
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9376 - 9385
  • [8] The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor
    Katsakhyan, Levon
    Baraban, Ezra G.
    Dumoff, Kimberly L.
    Burger, Robert A.
    Parikh, Rupal
    Cooper, Kumarasen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (02) : 175 - 179
  • [9] IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMA
    Park, Junsik
    Kim, Jung Chul
    Lee, Mi-Ran
    Lee, Joohyang
    Kim, Sunghoon
    Kim, Sang Wun
    Lee, Jung-Yun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A28 - A29
  • [10] The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma.
    Kim, Rachel Soyoun
    Malcolmson, Janet
    Li, Xuan
    Bernardini, Marcus
    Hogen, Liat Frida
    May, Taymaa
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)